Amundi EUR Floating Rate Corporate Bond ESG UCITS ETF (AFRN) ニュース

got 11500 now MLGO

Not partial trial, but the conclusions that the late starter results vs. early on drug was out of necessity based only on those patients in Australia that made it into the OLE.

Shade Thrower, so you are implying that the multi-year Blarcamesine treatment results from Australian only

Go buy it with your money, put your money where your mouth is. What can you use the token for, it's not real currency,  it's a token.

thinking about something

Saturday review and some perspective. Current market cap is 647k. Minus debts of 230k, net mc value is 415k. Attrition of 1% at 347 monthly X 12=4,164 X 12= 416,400.
Factor in 2.5 million financing, possible debt pay off, and 2 upcoming divisions launch in crypto and bio, so we are essentia

I believe it's over. Tax next year going to be alot less than this year. I know not funny.

No animals please lol

Great! Another worthless post from you! Ignored!!!! Bye!

https://investorshub.advfn.com/uimage/uploads/2025/1/18/axzrgxrp_!_18_15d_11am_2018_BO_OMG.jpg



Doesn't show up on this chart here though.........because having the ACTUAL number(s) is essential.

https://investorshub.advfn.com/uimage/uploads/2025/1/18/e

Not partial trial, but the conclusions that the late starter results vs. early on drug was out of necessity based only on those patients in Australia that made it into the OLE. I believe n=76. The other international trial sites started to enroll quite late and did not run beyond 96 weeks for the la

Thanks BB.

:O

You better write it on a Big Mac wrapper.

Volt Lithium Corp. ( VLT:TSV ; VLTLF:US; I2D:FSE)
https://www.streetwisereports.com/article/2024/12/20/revolutionizing-lithium-extraction-major-advances-in-dle-technology-propel-u-s-production-growth.html?utm_source=delivra&utm_medium=email&utm_campaign=TRR12-24-2024&utm_id=47084495
A

ROI of his trading history for the past 10 years. ROI is in %.

Gawd, I wish the pumpers would stop pumping my stocks. I mean you
@Drugdoctor2014
9:39 AM · Aug 7, 2023 · 10K Views

https://twitter.com/GeorgeASharp/status/1688560532989542400?t=f9rio_UeybLpatGTQUwifg&s=19

OT: Innovation is the driving force for semiconductor industry. There is Thunderbolt Laser technology soon could make chips at fraction of the current pricing, especially for high end chips.

But how?.... we need filings.

I was thinking ROI of all assets

Large accumulated loss - yes.

Potential tax loss carryforward - yes.

Something that would motivate an acquisition of nwbo - no.

An acquirer cannot simply offset gains in other businesses against past nwbo losses. Won't pass IRS muster. Look for info on